The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 11, 2015, Pages 2036-2047

  Li, J ^a   Li, R J ^a   Lv, G Y ^a   Liu, H Q ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Hepatic ischemia reperfusion injury; Inflammation; Liver transplantation; Oxidative stress; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; COMPLEMENT; ENDOTHELIN; GLUCOSE; GLUTATHIONE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHALATION ANESTHETIC AGENT; INTERLEUKIN 1; INTERLEUKIN 10; METHYLPREDNISOLONE; NITRIC OXIDE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; XANTHINE OXIDASE; PROTECTIVE AGENT;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; EARLY INTERVENTION; GENETIC ASSOCIATION; HERB; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; KUPFFER CELL; LIVER ISCHEMIA; LYMPHOCYTE; MEDICAL DECISION MAKING; MEMBRANE PERMEABILITY; METABOLIC ACIDOSIS; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REGULATORY MECHANISM; REPERFUSION INJURY; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; ANOXIA; LIVER; LIVER DISEASES; METABOLISM; VASCULARIZATION;

ANOXIA; APOPTOSIS; HUMANS; INFLAMMATION; LIVER; LIVER DISEASES; OXIDATIVE STRESS; PROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RISK FACTORS;

EID: 84942234187     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. PERALTA C, JIMÉNEZ-CASTRO MB, GRACIA-SANCHO J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol 2013; 59: 1094-1106.
2. ZHAI Y, PETROWSKY H, HONG JC, BUSUTTIL RW, KUPIECWEGLINSKI JW. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10: 79-89.
3. ELTZSCHIG HK, COLLARD CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004; 70: 71-86.
4. VIDELA LA. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 2009; 1: 72-78.
5. GUO WA. The search for a magic bullet to fight multiple organ failure secondary to ischemia/reperfusion injury and abdominal compartment syndrome. J Surg Res 2013; 184: 792-793.
6. TEOH NC. Hepatic ischemia reperfusion injury: Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly. J Gastroenterol Hepatol 2011; 26: 180-187.
7. KIM PK, VALLABHANENI R, ZUCKERBRAUN BS, MCCLOSKEY C, VODOVOTZ Y, BILLIAR TR. Hypoxia renders hepatocytes susceptible to cell death by nitric oxide. Cell Mol Biol (Noisy-le-grand) 2005; 51: 329-335.
8. VON HEESEN M, MÜLLER S, KEPPLER U, STROWITZKI MJ, SCHEUER C, SCHILLING MK, MENGER MD, MOUSSAVIAN MR. Preconditioning by cilostazol protects against cold hepatic ischemia-reperfusion injury. Ann Transplant 2015; 20: 160-168.
9. JAESCHKE H. Reperfusion injury after warm ischemia or cold storage of the liver: role of apoptotic cell death. Transplant Proc 2002; 34: 2656-2658.
10. FERNANDEZ V, TAPIA G, VIDELA LA. Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron. World J Hepatol 2012; 4: 119-128.
11. VAN GOLEN RF, REINIERS MJ, OLTHOF PB, VAN GULIK TM, HEGER M. Sterile inflammation in hepatic ischemia/ reperfusion injury: present concepts and potential therapeutics. J Gastroenterol Hepatol 2013; 28: 394-400.
12. SWIFT C, GARNER JP. Non-operative management of liver trauma. J R Army Med Corps. 2012; 158: 85-95.
13. AMADOR A, GRANDE L, MARTI J, DEULOFEU R, MIQUEL R, SOLÁ A, RODRIGUEZ-LAIZ G, FERRER J, FONDEVILA C, CHARCO R, FUSTER J, HOTTER G, GARCÍA-VALDECASAS JC. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007; 7: 2180-2189.
14. CASILLAS-RAMIREZ A, MOSBAH IB, RAMALHO F, ROSELLOCATAFAU J, PERALTA C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79: 1881-1894.
15. DE GROOT H, RAUEN U. Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc 2007; 39: 481-484.
16. MASSIP-SALCEDO M, ROSELLO-CATAFAU J, PRIETO J, AVILA MA, PERALTA C. The response of the hepatocyte to ischemia. Liver Int 2007; 27: 6-16.
17. BILZER M, GERBES AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000; 32: 508-515.
18. HEIJNEN BH, ELKHALOUFI Y, STRAATSBURG IH, VAN GULIK TM. Influence of acidosis and hypoxia on liver ischemia and reperfusion injury in an in vivo rat model. J Appl Physiol 2002; 93: 319-323.
19. JIANGE HE, AIHONG REN, CICHENG SHI, XIAOMAN HOU, YIGE ZHAO. Mechanism and prevention of hepatic ischemia-reperfusion injury. Journal of Henan University of Science & Technology (Medical science edition) 2012; 30: 235-237. (In Chinese)
20. GNAIGER E, KUZNETSOV AV, RIEGER G, AMBERGER A, FUCHS A, STADLMANN S, EBERL T, MARGREITER R. Mitochondrial defects by intracellular calcium overload versus endothelial cold ischemia/reperfusion injury. Transpl Int 2000; 13: 555-557.
21. JAESCHKE H, WOOLBRIGHT BL. Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev 2012; 26: 103-114.
22. NISHIMURA Y, ROMER LH, LEMASTERS JJ. Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: the pH paradox and cytoprotection by glucose, acidotic pH, and glycine. Hepatology 1998; 27: 1039-1049.
23. BRADFORD BU, MAROTTO M, LEMASTERS JJ, THURMAN RG. New, simple models to evaluate zone-specific damage due to hypoxia in the perfused rat liver: time course and effect of nutritional state. J Pharmacol Exp Ther 1986; 236: 263-268.
24. NIEMINEN AL, DAWSON TL, GORES GJ, KAWANISHI T, HERMAN B, LEMASTERS JJ. Protection by acidotic pH and fructose against lethal injury to rat hepatocytes from mitochondrial inhibitors, ionophores and oxidant chemicals. Biochem Biophys Res Commun 1990; 167: 600-606.
25. JAESCHKE H, BAUTISTA AP, SPOLARICS Z, SPITZER JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 1991; 15: 277-284.
26. SIRIUSSAWAKUL A, ZAKY A, LANG JD. Role of nitric oxide in hepatic ischemia-reperfusion injury.World J Gastroenterol 2010; 16: 6079-6086.
27. ECKMANN DM, ARMSTEAD SC. Influence of endothelial glycocalyx degradation and surfactants on air embolism adhesion. Anesthesiology 2006; 105: 1220-1227.
28. SHIRATORI Y, KIRIYAMA H, FUKUSHI Y, NAGURA T, TAKADA H, HAI K, KAMII K. Modulation of ischemia-reperfusion-induced hepatic injury by Kupffer cells. Dig Dis Sci 1994; 39: 1265-1272.
29. TEOH NC, FARRELL GC. Hepatic ischemia reperfusion injury pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
30. LINFERT D CHOWDHRY T, RABB H. Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 2009; 23: 1-10.
31. QIANG Z, RUI-MING Z, DE-PING LI. Recent advances of the research on the Mechanisms of Hepatic ischemia-reperfusion injury. Inner Mongolia Med 2007; 39: 831-834. (In Chinese)
32. TANG-LEI S, WEI-YAO C. Activation of Kupffer cells and reperfusion injury in liver transplantation. Chinese Journal of General Surgery 2001; 16: 51-52. (In Chinese)
33. KATO A, GABAY C, OKAYA T, LENTSCH AB. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia reperfusion. Am J Pathol 2002; 161: 1797-1803.
34. BOROS P, BROMBERG JS. New cellular and molecular immune pathways in ischemia reperfusion injury. Am J Transplant 2006; 6: 652-658.
35. SHAH V, KAMATH PS. Nitric oxide in liver transplantation: Pathobiology and clinical implication. J Liver Transpl 2003; 9: 1-11.
36. KHANDOGA A, BIBERTHALER P, ENDERS G, TEUPSER D, AXMANN S, LUCHTING B, HUTTER J, MESSMER K, KROMBACH F. P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo. J Shock 2002; 18: 529-535.
37. FRIEDL IP, GUERRA EE, CRAMER T, GIACHERIO D, TOLEDO-PEREYRA LH, TILL GO. Histamine and xanthine oxidase in hepatic ischemia-reperfusion injury. Transplant Proc 1990; 22: 513-515.
38. LIU PG, HE SQ, ZHANG YH, WU J. Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice. World J Gastroenterol 2008; 14: 2832-2837.
39. ERTURK E. Ischemia-reperfusion injury and volatile anesthetics. BioMed Res Int 2014; 1-7.
40. PHILLIPS L, TOLEDO AH, LOPEZ-NEBLINA F, ANAYA-PRADO R, TOLEDO-PEREYRA LH. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg 2009; 22: 46-55.
41. JENNINGS RB, SHEN AC, HILL ML, GANOTE CE, HERDSON PB. Mitochondrial matrix densities in myocardial ischemia and autolysis. Exp Mol Pathol 1978; 29: 55-65.
42. SAMMUT IA, BURTON K, BALOGUN E, SARATHCHANDRA P, BROOKS KJ, BATES TE, GREEN CJ. Time-dependent impairment of mitochondrial function after storage and transplantation of rabbit kidneys. Transplantation 2000; 69: 1265-1275.
43. HOEKSTRA LT, VAN TRIGT JD, REINIERS MJ, BUSCH OR, GOUMA DJ, VAN GULIK TM. Vascular occlusion or not during liver resection: the continuing story. Dig Surg 2012; 29: 35-42.
44. LESURTEL M, LEHMANN K, DE ROUGEMONT O, CLAVIEN PA. Clamping techniques and protecting strategies in liver surgery. HPB (Oxford) 2009; 11: 290-295.
45. VAN DEN BROEK MA, BLOEMEN JG, DELLO SA, VAN DE POLL MC, OLDE DAMINK SW, DEJONG CH. Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol 2011; 55: 337-345.
46. BELGHITI J, NOUN R, ZANTE E, BALLET T, SAUVANET A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996; 224: 155-161.
47. VAN GULIK TM, DE GRAAF W, DINANT S, BUSCH OR, GOUMA DJ. Vascular occlusion techniques during liver resection. Dig Surg 2007; 24: 274-281.
48. HOTI E, SALLOUM C, AZOULAY D. Hepatic resection with in situ hypothermic perfusion is superior to other resection techniques. Dig Surg 2011; 28: 94-99.
49. AZOULAY D, ESHKENAZY R, ANDREANI P, CASTAING D, ADAM R, ICHAI P, NAILI S, VINET E, SALIBA F, LEMOINE A, GILLON MC, BISMUTH H. In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 2005; 241: 277-285.
50. DINANT S, ROSEBOOM HJ, LEVI M, VAN VLIET AK, VAN GULIK TM. Hypothermic in situ perfusion of the porcine liver using Celsior or Ringer-lactate solution. Langenbecks Arch Surg 2009; 394: 143-150.
51. ABU-AMARA M, GURUSAMY K, HORI S, GLANTZOUNIS G, FULLER B, DAVIDSON BR. Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB (Oxford) 2010; 12: 4-14.
52. SAIDI RF, CHANG J, VERB S, BROOKS S, NALBANTOGLU I, ADSAY V, JACOBS MJ. The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver. Am J Surg 2007; 193: 345-347.
53. ORCI LA, TOSO C, MENTHA G, MOREL P, MAJNO PE. Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia-reperfusion injury and surgical stress response in patients undergoing liver resection. Br J Surg 2013; 100: 600-609.
54. OCUIN LM, ZENG S, CAVNAR MJ, SORENSON EC, BAMBOAT ZM, GREER JB, KIM TS, POPOW R, DEMATTEO RP. Nilotinib protects the mur ine liver from ischemia/ reperfusion injury. J Hepatol 2012; 57: 766-773.
55. ELIAS-MIRÓ M, JIMÉNEZ CASTRO M, PERALTA C. Injury Associated with Liver Transplantation in 2011: Past and Future. 2012. http://www.intechopen.com/books/liver-t ransplantat ion-basic-issues/ ischemiareper fusion-injur y-associated-wi th-l i ver-transplantation-in-2011-past-and-future
56. KIM I, RODRIGUEZ-ENRIQUEZ S, LEMASTERS JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007: 462: 245-253.
57. KLAASSEN CD, REISMAN SA. Nrf2 the rescue effects of the antioxidative electrophilic response on the liver. Toxicol Appl Pharmacol 2010; 244: 57-65.
58. PRATSCHKE S, ANGELE MK, GRÜTZNER U, TUFMAN A, BILZER M, LOEHE F, JAUCH KW, SCHAUER RJ. GSH attenuates organ injury and improves function after transplantation of fatty livers. Eur Surg Res 2010; 45: 13-19.
59. SCHAUER RJ, KALMUK S, GERBES AL, LEIDERER R, MEISSNER H, SCHILDBERG FW, MESSMER K, BILZER M. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol 2004; 10: 864-870.
60. JEGATHEESWARAN S, SIRIWARDENA AK. Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB (Oxford) 2011; 13: 71-78.
61. ATALLA SL, TOLEDO-PEREYRA LH, MACKENZIE GH, CEDERNA JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985; 40: 584-590.
62. AMERSI F, SHEN XD, ANSELMO D, MELINEK J, IYER S, SOUTHARD DJ, KATORI M, VOLK HD, BUSUTTIL RW, BUELOW R, KUPIEC-WEGLINSKI JW. Ex vivo exposure to carbon monoxide prevents hepatic ischemiareperfusion injury through p38 MAP kinase pathway. Hepatology 2002; 35: 815-823.
63. KUME M, YAMAMOTO Y, SAAD S, GOMI T, KIMOTO S, SHIMABUKURO T, YAGI T, NAKAGAMI M, TAKADA Y, MORIMOTO T, YAMAOKA Y. Ischemia preconditioning of the liver in rats implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128: 251-258.
64. DE ROUGEMONT O, LEHMANN K, CLAVIEN PA. Preconditioning, organ preservation, and post-conditioning to prevent ischemia reperfusion injury to the liver. Liver Transpl 2009; 15: 1172-1182.
65. SERAFÍN A, FERNÁNDEZ-ZABALEGUI L, PRATS N, WU ZY, ROSELLÓ-CATAFAU J, PERALTA C. Ischemic preconditioning tolerance to hepatic ischemia-reperfusion injury. Histol Histopathol 2004; 19: 281-289.
66. SCHAUER RJ, GERBES AL, VONIER D, OP DEN WINKEL M, FRAUNBERGER P, BILZER M. Induction of cellular resistance against Kupffer cell-derived oxidant stress a novel concept of hepatoprotection by ischemic preconditioning. Hepatology 2003; 37: 286-295.
67. DAL PONTE C, ALCHERA E, FOLLENZI A, IMARISIO C, PRAT M, ALBANO E, CARINI R. Pharmacological postconditioning protects against hepatic ischemia-reperfusion injury. Liver Transpl 2011; 17: 474-482.
68. ARAI M, THURMAN RG, LEMASTERS JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic precondition of sinusoidal endothelial cells against storage reperfusion injury in rat livers. Hepatology 2000; 32: 297-302.
69. NAKAYAMA H, YAMAMOTO Y, KUME M, YAMAGAMI K, YAMAMOTO H, KIMOTO S, ISHIKAWA Y, OZAKI N, SHIMAHARA Y, YAMAOKA Y. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999; 126: 945-954.
70. KIEMER AK, GERBES AL, BILZER M, VOLLMAR AM. The atrial natriuretic peptide and cGMP novel activators of the heat shock response in rat livers. Hepatology 2002; 35: 88-94.
71. ARAI M, TEJIMA K, IKEDA H, TOMIYA T, YANASE M, INOUE Y, NAGASHIMA K, NISHIKAWA T, WATANABE N, OMATA M, FUJIWARA K. Ischemia preconditioning in liver pathophysiology. Hepatology 2007; 22: 65-67.
72. LV X, YANG L, TAO K, LIU Y, YANG T, CHEN G, YU W, LV H, WU F. Isoflurane preconditioning at clinically relevant doses induce protective effects of heme oxygenase-1 on hepatic ischemia reperfusion in rats. BMC Gastroenterol 2011; 11: 31.
73. BECK-SCHIMMER B, BREITENSTEIN S, URECH S, DE CONNO E, WITTLINGER M, PUHAN M, JOCHUM W, SPAHN DR, GRAF R, CLAVIEN PA. A Randomized controlled trail on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2002; 248: 909-918.
74. HE L, LEMASTERS JJ. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 2002; 512: 1-7.
75. THERUVATH TP, SNODDY MC, ZHONG Z, LEMASTERS JJ. Mitochondrial permeability transition in liver ischemia and reperfusion role of c-Jun N-terminal kinase2. Transplantation 2008; 85: 1500-1504.
76. OKATANI Y, WAKATSUKI A, REITER RJ, ENZAN H, MIYAHARA Y. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. Eur J Pharmacol 2003; 469: 145-152.
77. OKATANI Y, WAKATSUKI A, ENZAN H, MIYAHARA Y. Edaravone protects against ischemia-reperfusioninduced oxidative damage to mitochondria in rat liver. Eur J Pharmacol 2003; 465: 163-170.
78. TOTSUKA O, TAKEYOSHI I, TSUTSUMI H, ARAKAWA K, AKAO T, MURAOKA M, OHWADA S, MATSUMOTO K, MORISHITA Y. Effects of a free radical scavenger, MCI-186, in ischemia-reperfusion injury during extended liver resection in dogs. Hepatogastroenterology 2005; 52: 1545-1548.
79. ABE T, UNNO M, TAKEUCHI H, KAKITA T, KATAYOSE Y, RIKIYAMA T, MORIKAWA T, SUZUKI M, MATSUNO S. A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo. J Gastrointest Surg 2004; 8: 604-615.
80. KUBOKI S, OKAYA T, SCHUSTER R, BLANCHARD J, DENENBERG A, WONG HR, LENTSCH AB. Hepatocyte NFkappa B activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia. Am J Physiol Gastrointest Liver Physiol 2007; 292: 201-207.
81. SAKAI N, VAN SWERINGEN HL, SCHUSTER R, BLANCHARD J, BURNS JM, TEVAR AD, EDWARDS MJ, LENTSCH AB. Receptor activator of nuclear factor-kappaB lig-and (RANKL) protects against hepatic ischemia/ reperfusion injury in mice. Hepatology 2012; 55: 888-897.
82. RICCIARDI R, FOLEY DP, QUARFORDT SH, SAAVEDRA JE, KEEFER LK, WHEELER SM, DONOHUE SE, CALLERY MP, MEYERS WC. V-PYRRO/NO: an hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion. Transplantation 2001; 71: 193-198.
83. KATSUMI H, NISHIKAWA M, YASUI H, YAMASHITA F, HASHIDA M. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. J Control Release 2009; 140: 12-17.
84. DUMOND JF, KING SB. The chemistry of nitroxyl-releasing compounds. Antioxid Redox Signal 2011; 14: 1637-1648.
85. AL-SA'DONI H, FERRO A. S-Nitrosothiols: a class of nitric oxide-donor drugs. Clin Sci (Lond) 2000; 98: 507-520.
86. LIANG R, NICKKHOLGH A, KERN M, SCHNEIDER H, BENZING S, ZORN M, BÜCHLER MW, SCHEMMER P. Green tea extract ameliorates reperfusion injury to rat livers after warm ischemia in a dose-dependent manner. Mol Nutr Food Res 2011; 5: 855-863.
87. HASSAN-KHABBAR S, COTTART CH, WENDUM D, VIBERT F, CLOT JP, SAVOURET JF, CONTI M, NIVET-ANTOINE V. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion a possible strategy in liver surgery. Liver Transpl 2008; 14: 451-459.
88. CHENG F, LI Y, FENG L, LI S. Effects of tetrandine on ischemia-reperfusion injury in mouse liver. Transplant Proc 2008; 40: 2163-2166